Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Holds Zydus Cadila Responsible For ‘Repeat Violations’
Agency May Withhold Approval Of Abbreviated New Drug Applications
Nov 19 2019
•
By
Akriti Seth
FDA releases details of the warning letter sent to Zydus Cadila • Source: Shutterstock
More from Manufacturing
More from Business